<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Inpatient Antimicrobial Guide</title>
<style>
body { font-family: Arial, sans-serif; margin:0; padding:0; display:flex; }
#sidebar { width:250px; background:#f8f8f8; padding:10px; border-right:1px solid #ccc; height:100vh; overflow-y:auto; }
#sidebar h2 { margin-top:0; }
#sidebar ul { list-style:none; padding-left:0; }
#sidebar li { margin:5px 0; cursor:pointer; color:#007BFF; }
#content { flex:1; padding:20px; overflow-y:auto; }
.expandable { background:#e2e2e2; padding:10px; margin:5px 0; cursor:pointer; border-radius:4px; }
.hidden { display:none; }
table { width:100%; border-collapse:collapse; margin:10px 0; }
th, td { border:1px solid #ccc; padding:5px; text-align:left; }
th { background:#f0f0f0; }
a { color:#007BFF; }
</style>
<script>
function showContent(id){
    document.querySelectorAll('#content > div').forEach(s=>s.style.display='none');
    var section = document.getElementById(id);
    if(section) section.style.display='block';
}
function toggleVisibility(id){
    var e = document.getElementById(id);
    e.style.display = (e.style.display === 'block') ? 'none' : 'block';
}
</script>
</head>
<body>

<div id="sidebar">
<h2>Sections</h2>
<ul>
<li onclick="showContent('homepage')">Home</li>
<li onclick="showContent('bacteria')">Bacterial Infections</li>
<li onclick="showContent('fungi')">Fungal Infections</li>
<li onclick="showContent('viruses')">Viral Infections</li>
<li onclick="showContent('pathogen')">Pathogen-Based Guidance</li>
<li onclick="showContent('overview')">Pathogen Overview</li>
<li onclick="showContent('classes')">Antibiotic Classes / Escalation</li>
<li onclick="showContent('references')">References</li>
</ul>
</div>

<div id="content">

<!-- Homepage -->
<div id="homepage">
<div style="text-align:center; margin-top:50px;">
<img src="mutant-icon.png" alt="Mutant Icon" style="width:150px; height:150px; margin-bottom:20px;">
<h1>Inpatient Antimicrobial Guide</h1>
<p>Select a section from the sidebar to view empiric therapy, culture-directed therapy, Gram-stain/diagnostic guidance, pathogen-specific recommendations, and detailed pathogen information.</p>
</div>
</div>

<!-- Bacterial Infections -->
<div id="bacteria" style="display:none">
<h2>Bacterial Infections</h2>

<!-- Gram-Positive Cocci -->
<div class="expandable" onclick="toggleVisibility('GramPositiveCocci')">Gram-Positive Cocci</div>
<div id="GramPositiveCocci" class="hidden">
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Streptococcus spp.</td><td>Penicillin G</td><td>Penicillin G (per susceptibility)</td><td>12–24 MU/day IV</td><td>10–14 days</td><td>Adjust per culture</td></tr>
<tr><td>Staphylococcus aureus (MSSA)</td><td>Nafcillin/Oxacillin</td><td>Same</td><td>2 g IV q4h</td><td>10–14 days</td><td>Monitor renal</td></tr>
<tr><td>MRSA</td><td>Vancomycin</td><td>Same</td><td>15 mg/kg IV q12h</td><td>10–14 days</td><td>Monitor trough & renal</td></tr>
<tr><td>Enterococcus spp.</td><td>Ampicillin ± Gentamicin</td><td>Per susceptibility</td><td>Ampicillin 2 g IV q4h; Gent 3 mg/kg/day</td><td>4–6 weeks</td><td>Adjust renal</td></tr>
</table>
</div>

<!-- Gram-Positive Rods -->
<div class="expandable" onclick="toggleVisibility('GramPositiveRods')">Gram-Positive Rods</div>
<div id="GramPositiveRods" class="hidden">
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Mycobacterium tuberculosis</td><td>RIPE therapy</td><td>Same</td><td>Per guidelines</td><td>6 months</td><td>DOT recommended</td></tr>
<tr><td>Corynebacterium spp.</td><td>Vancomycin / Penicillin</td><td>Same</td><td>Vancomycin 15 mg/kg IV q12h</td><td>10–14 days</td><td>Depends on species/site</td></tr>
<tr><td>Nocardia spp.</td><td>TMP-SMX</td><td>Same</td><td>15 mg/kg/day TMP IV/PO</td><td>6–12 months</td><td>CNS involvement requires higher dose</td></tr>
<tr><td>Clostridium spp.</td><td>Metronidazole</td><td>Same</td><td>500 mg IV q8h</td><td>10–14 days</td><td>Include surgery for necrotizing infections</td></tr>
<tr><td>Actinomyces spp.</td><td>Penicillin G</td><td>Same</td><td>18–24 MU/day IV</td><td>6–12 months</td><td>Chronic infections often require prolonged therapy</td></tr>
</table>
</div>

<!-- Gram-Negative Cocci -->
<div class="expandable" onclick="toggleVisibility('GramNegativeCocci')">Gram-Negative Cocci</div>
<div id="GramNegativeCocci" class="hidden">
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Neisseria meningitidis</td><td>Ceftriaxone</td><td>Same</td><td>2 g IV q12h</td><td>7 days</td><td>Close contacts require prophylaxis</td></tr>
<tr><td>Neisseria gonorrhoeae</td><td>Ceftriaxone + Azithromycin</td><td>Same</td><td>500 mg IM ×1 + 1 g PO ×1</td><td>Single dose</td><td>Adjust if weight >150 kg</td></tr>
<tr><td>Moraxella catarrhalis</td><td>Amoxicillin-clavulanate</td><td>Same</td><td>875/125 mg PO BID</td><td>5–7 days</td><td>Respiratory pathogen</td></tr>
</table>
</div>

<!-- Gram-Negative Rods -->
<div class="expandable" onclick="toggleVisibility('GramNegativeRods')">Gram-Negative Rods</div>
<div id="GramNegativeRods" class="hidden">
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Enterobacteriaceae</td><td>Cefepime / Meropenem</td><td>Per susceptibility</td><td>2 g IV q8h / 1 g IV q8h</td><td>7–10 days</td><td>Adjust per renal function</td></tr>
<tr><td>Burkholderia cepacia</td><td>Meropenem + TMP-SMX</td><td>Same</td><td>Meropenem 1 g IV q8h; TMP-SMX 15 mg/kg/day TMP</td><td>10–14 days</td><td>CF patients often affected</td></tr>
<tr><td>Bacteroides spp.</td><td>Metronidazole ± Beta-lactam</td><td>Same</td><td>500 mg IV q8h</td><td>7–10 days</td><td>Intra-abdominal source control essential</td></tr>
<tr><td>Prevotella spp.</td><td>Metronidazole</td><td>Same</td><td>500 mg IV q8h</td><td>7–10 days</td><td>Oral anaerobes</td></tr>
</table>
</div>

<!-- Aerobes & Anaerobes -->
<div class="expandable" onclick="toggleVisibility('AerobesAnaerobes')">Aerobes & Anaerobes</div>
<div id="AerobesAnaerobes" class="hidden">
<table>
<tr><th>Type</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Aerobes (Pseudomonas, Acinetobacter)</td><td>Cefepime / Piperacillin-Tazobactam</td><td>Same</td><td>2 g IV q8h / 4.5 g IV q6–8h</td><td>7–10 days</td><td>Adjust per renal and cultures</td></tr>
<tr><td>Anaerobes</td><td>Metronidazole ± Beta-lactam</td><td>Same</td><td>500 mg IV q8h</td><td>7–14 days</td><td>Intra-abdominal, dental, soft tissue</td></tr>
</table>
</div>

<!-- Intracellular Pathogens -->
<div class="expandable" onclick="toggleVisibility('Intracellular')">Intracellular Pathogens</div>
<div id="Intracellular" class="hidden">
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Chlamydia spp.</td><td>Doxycycline</td><td>Same</td><td>100 mg PO BID</td><td>7–14 days</td><td>Alternative: Azithromycin</td></tr>
<tr><td>Legionella spp.</td><td>Levofloxacin</td><td>Same</td><td>750 mg IV/PO q24h</td><td>10–14 days</td><td>Adjust renal</td></tr>
<tr><td>Rickettsia spp.</td><td>Doxycycline</td><td>Same</td><td>100 mg PO BID</td><td>7–14 days</td><td>Start early</td></tr>
<tr><td>Mycoplasma pneumoniae</td><td>Azithromycin</td><td>Same</td><td>500 mg PO day1 → 250 mg PO ×4 days</td><td>5 days</td><td>Alternative: Doxycycline</td></tr>
<tr><td>Coxiella burnetii</td><td>Doxycycline</td><td>Same</td><td>100 mg PO BID</td><td>14 days acute, 18 months chronic</td><td>Chronic: add hydroxychloroquine</td></tr>
</table>
</div>

<!-- Fungal Infections -->
<div id="fungi" style="display:none">
<h2>Fungal Infections</h2>
<div class="expandable" onclick="toggleVisibility('Candida')">Candida spp.</div>
<div id="Candida" class="hidden">
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th></tr>
<tr><td>Candida albicans</td><td>Fluconazole</td><td>Same</td><td>400 mg IV/PO daily</td><td>14 days</td></tr>
<tr><td>Non-albicans Candida</td><td>Echinocandin</td><td>Adjust per susceptibility</td><td>Caspofungin 70 mg IV day1 → 50 mg IV daily</td><td>14–21 days</td></tr>
</table>
</div>
<div class="expandable" onclick="toggleVisibility('Aspergillus')">Aspergillus spp.</div>
<div id="Aspergillus" class="hidden">
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Culture-Directed Therapy</th><th>Dose</th><th>Duration</th></tr>
<tr><td>Aspergillus spp.</td><td>Voriconazole</td><td>Same</td><td>6 mg/kg IV q12h ×2 then 4 mg/kg IV q12h</td><td>6–12 weeks</td></tr>
</table>
</div>
</div>

<!-- Viral Infections -->
<div id="viruses" style="display:none">
<h2>Viral Infections</h2>
<div class="expandable" onclick="toggleVisibility('HSV')">HSV/VZV</div>
<div id="HSV" class="hidden">
<table>
<tr><th>Virus</th><th>Therapy</th><th>Dose</th><th>Duration</th></tr>
<tr><td>HSV-1/2</td><td>Acyclovir</td><td>5–10 mg/kg IV q8h</td><td>7–14 days</td></tr>
<tr><td>VZV (shingles)</td><td>Acyclovir</td><td>10 mg/kg IV q8h</td><td>7–10 days</td></tr>
</table>
</div>
<div class="expandable" onclick="toggleVisibility('Influenza')">Influenza</div>
<div id="Influenza" class="hidden">
<table>
<tr><th>Virus</th><th>Therapy</th><th>Dose</th><th>Duration</th></tr>
<tr><td>Influenza A/B</td><td>Oseltamivir</td><td>75 mg PO BID</td><td>5 days</td></tr>
</table>
</div>
</div>

<!-- Pathogen-Based Guidance -->
<div id="pathogen" style="display:none">
<h2>Pathogen-Based Guidance</h2>
<p>Select therapy according to Gram-stain and culture results. Use narrowest effective spectrum. Adjust for renal/liver function and severity.</p>
</div>

<!-- Pathogen Overview -->
<div id="overview" style="display:none">
<h2>Pathogen Overview</h2>

<!-- Bacteria -->
<div class="expandable" onclick="toggleVisibility('StaphylococcusOverview')">Staphylococcus spp.</div>
<div id="StaphylococcusOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide<br>
<strong>Risk Factors:</strong> Indwelling devices, post-surgical, immunocompromised<br>
<strong>Vectors / Reservoirs:</strong> Skin, nares<br>
<strong>Resistance:</strong> MRSA increasing globally; some strains have vancomycin intermediate resistance<br>
<strong>Pathophysiology:</strong> Toxin-mediated diseases, biofilm formation, invasive infections<br>
<strong>Clinical Notes:</strong> Causes SSTIs, bacteremia, endocarditis, osteomyelitis</p>
</div>

<div class="expandable" onclick="toggleVisibility('StreptococcusOverview')">Streptococcus spp.</div>
<div id="StreptococcusOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide<br>
<strong>Risk Factors:</strong> Children (group A), elderly, comorbidities<br>
<strong>Vectors / Reservoirs:</strong> Oropharynx, skin<br>
<strong>Resistance:</strong> Penicillin generally effective; macrolide resistance varies<br>
<strong>Pathophysiology:</strong> Exotoxins, post-infectious sequelae<br>
<strong>Clinical Notes:</strong> Causes pharyngitis, pneumonia, endocarditis, necrotizing fasciitis</p>
</div>

<div class="expandable" onclick="toggleVisibility('MycobacteriumOverview')">Mycobacterium spp.</div>
<div id="MycobacteriumOverview" class="hidden">
<p><strong>Prevalence:</strong> TB endemic regions worldwide<br>
<strong>Risk Factors:</strong> Immunocompromised, close contacts, HIV<br>
<strong>Vectors / Reservoirs:</strong> Aerosol droplets<br>
<strong>Resistance:</strong> MDR and XDR TB rising<br>
<strong>Pathophysiology:</strong> Intracellular survival in macrophages, granuloma formation<br>
<strong>Clinical Notes:</strong> Pulmonary, extrapulmonary TB, chronic infection</p>
</div>

<div class="expandable" onclick="toggleVisibility('NocardiaOverview')">Nocardia spp.</div>
<div id="NocardiaOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, rare<br>
<strong>Risk Factors:</strong> Immunocompromised (steroids, transplant)<br>
<strong>Vectors / Reservoirs:</strong> Soil, environment<br>
<strong>Resistance:</strong> TMP-SMX sensitive, variable resistance<br>
<strong>Pathophysiology:</strong> Filamentous, partially acid-fast, opportunistic infection<br>
<strong>Clinical Notes:</strong> Pulmonary, CNS, disseminated disease</p>
</div>

<div class="expandable" onclick="toggleVisibility('CorynebacteriumOverview')">Corynebacterium spp.</div>
<div id="CorynebacteriumOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide<br>
<strong>Risk Factors:</strong> Immunocompromised, invasive devices<br>
<strong>Vectors / Reservoirs:</strong> Skin, mucosa<br>
<strong>Resistance:</strong> Some strains resistant to penicillin<br>
<strong>Pathophysiology:</strong> Exotoxin production in diphtheria; opportunistic infections<br>
<strong>Clinical Notes:</strong> Diphtheria, bloodstream infections, endocarditis</p>
</div>

<div class="expandable" onclick="toggleVisibility('BacteroidesOverview')">Bacteroides spp.</div>
<div id="BacteroidesOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, commensal in gut<br>
<strong>Risk Factors:</strong> Abdominal surgery, perforated viscus<br>
<strong>Vectors / Reservoirs:</strong> Human gut<br>
<strong>Resistance:</strong> Beta-lactamase producers common<br>
<strong>Pathophysiology:</strong> Anaerobic infection, abscess formation<br>
<strong>Clinical Notes:</strong> Intra-abdominal abscess, sepsis</p>
</div>

<div class="expandable" onclick="toggleVisibility('PrevotellaOverview')">Prevotella spp.</div>
<div id="PrevotellaOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, oral and gut flora<br>
<strong>Risk Factors:</strong> Dental procedures, aspiration<br>
<strong>Vectors / Reservoirs:</strong> Mouth, GI tract<br>
<strong>Resistance:</strong> Usually susceptible to metronidazole<br>
<strong>Pathophysiology:</strong> Anaerobic infection<br>
<strong>Clinical Notes:</strong> Aspiration pneumonia, oral infections</p>
</div>

<div class="expandable" onclick="toggleVisibility('ClostridiumOverview')">Clostridium spp.</div>
<div id="ClostridiumOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, environmental spores<br>
<strong>Risk Factors:</strong> Trauma, antibiotic use, immunocompromised<br>
<strong>Vectors / Reservoirs:</strong> Soil, gut flora<br>
<strong>Resistance:</strong> Some species resistant to clindamycin<br>
<strong>Pathophysiology:</strong> Toxin-mediated, anaerobic infection<br>
<strong>Clinical Notes:</strong> C. difficile colitis, gas gangrene, tetanus</p>
</div>

<div class="expandable" onclick="toggleVisibility('ActinomycesOverview')">Actinomyces spp.</div>
<div id="ActinomycesOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, rare<br>
<strong>Risk Factors:</strong> Poor dental hygiene, immunocompromised<br>
<strong>Vectors / Reservoirs:</strong> Oral cavity, GI tract<br>
<strong>Resistance:</strong> Penicillin sensitive<br>
<strong>Pathophysiology:</strong> Chronic granulomatous infection<br>
<strong>Clinical Notes:</strong> Cervicofacial, thoracic, abdominal infections</p>
</div>

<div class="expandable" onclick="toggleVisibility('BurkholderiaOverview')">Burkholderia spp.</div>
<div id="BurkholderiaOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, often in CF patients<br>
<strong>Risk Factors:</strong> Cystic fibrosis, immunocompromised<br>
<strong>Vectors / Reservoirs:</strong> Environmental soil and water<br>
<strong>Resistance:</strong> Multidrug resistance common<br>
<strong>Pathophysiology:</strong> Gram-negative bacilli, opportunistic pathogen<br>
<strong>Clinical Notes:</strong> Pulmonary infections, sepsis</p>
</div>

<!-- Fungi -->
<div class="expandable" onclick="toggleVisibility('CandidaOverview')">Candida spp.</div>
<div id="CandidaOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, hospital-acquired common<br>
<strong>Risk Factors:</strong> Central lines, ICU, immunosuppression<br>
<strong>Vectors / Reservoirs:</strong> GI tract, mucosa<br>
<strong>Resistance:</strong> Fluconazole resistance increasing<br>
<strong>Pathophysiology:</strong> Yeast infection, biofilm formation<br>
<strong>Clinical Notes:</strong> Candidemia, mucosal infections</p>
</div>

<div class="expandable" onclick="toggleVisibility('AspergillusOverview')">Aspergillus spp.</div>
<div id="AspergillusOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide, immunocompromised hosts<br>
<strong>Risk Factors:</strong> Neutropenia, transplant, steroids<br>
<strong>Vectors / Reservoirs:</strong> Environmental spores<br>
<strong>Resistance:</strong> Azole resistance rising<br>
<strong>Pathophysiology:</strong> Mold infection, angioinvasion<br>
<strong>Clinical Notes:</strong> Pulmonary, disseminated aspergillosis</p>
</div>

<!-- Viruses -->
<div class="expandable" onclick="toggleVisibility('HSVOverview')">HSV / VZV</div>
<div id="HSVOverview" class="hidden">
<p><strong>Prevalence:</strong> Worldwide<br>
<strong>Risk Factors:</strong> Immunosuppression, neonates<br>
<strong>Vectors / Reservoirs:</strong> Human mucosa, secretions<br>
<strong>Resistance:</strong> Rare acyclovir resistance in immunocompromised<br>
<strong>Pathophysiology:</strong> Latent viral infection, reactivation<br>
<strong>Clinical Notes:</strong> Mucocutaneous lesions, encephalitis</p>
</div>

<div class="expandable" onclick="toggleVisibility('InfluenzaOverview')">Influenza A/B</div>
<div id="InfluenzaOverview" class="hidden">
<p><strong>Prevalence:</strong> Seasonal, worldwide<br>
<strong>Risk Factors:</strong> Elderly, comorbidities, children<br>
<strong>Vectors / Reservoirs:</strong> Respiratory droplets<br>
<strong>Resistance:</strong> Oseltamivir resistance rare<br>
<strong>Pathophysiology:</strong> Respiratory viral infection<br>
<strong>Clinical Notes:</strong> Pneumonia, exacerbation of chronic illness</p>
</div>

</div> <!-- End Pathogen Overview -->

<!-- Repeat similar expandable for Streptococcus, Mycobacterium, Nocardia, Corynebacterium, Bacteroides, Prevotella, Clostridium, Actinomyces, Burkholderia, Candida, Aspergillus, HSV, Influenza -->
</div>

<!-- Antibiotic Classes / Escalation -->
<div id="classes" style="display:none">
<h2>Antibiotic Classes / Escalation</h2>
<table>
<tr><th>Class</th><th>Examples</th><th>Typical Use</th></tr>
<tr><td>Beta-lactams</td><td>Penicillins, Cephalosporins, Carbapenems</td><td>Broad empiric coverage; adjust per susceptibility</td></tr>
<tr><td>Glycopeptides</td><td>Vancomycin, Teicoplanin</td><td>MRSA and Gram-positive coverage</td></tr>
<tr><td>Fluoroquinolones</td><td>Levofloxacin, Ciprofloxacin</td><td>Gram-negative, atypical coverage</td></tr>
<tr><td>Macrolides</td><td>Azithromycin, Clarithromycin</td><td>Atypical bacteria, intracellular pathogens</td></tr>
<tr><td>Tetracyclines</td><td>Doxycycline</td><td>Intracellular pathogens, MRSA</td></tr>
<tr><td>Aminoglycosides</td><td>Gentamicin, Amikacin</td><td>Gram-negative synergy with beta-lactams</td></tr>
<tr><td>Antifungals</td><td>Fluconazole, Voriconazole, Amphotericin B</td><td>Yeast and mold infections</td></tr>
<tr><td>Antivirals</td><td>Acyclovir, Oseltamivir, Ganciclovir</td><td>HSV/VZV, Influenza, CMV</td></tr>
</table>
</div>

<!-- References -->
<div id="references" style="display:none">
<h2>References</h2>
<ul>
<li><a href="https://www.idsociety.org/practice-guideline/" target="_blank">IDSA Practice Guidelines</a></li>
<li><a href="https://www.nejm.org/" target="_blank">NEJM</a></li>
<li><a href="https://jamanetwork.com/" target="_blank">JAMA</a></li>
<li><a href="https://accessmedicine.mhmedical.com/" target="_blank">Harrison's Principles of Internal Medicine</a></li>
<li><a href="https://www.cdc.gov/antibiotic-use/" target="_blank">CDC Antibiotic Use Guidelines</a></li>
</ul>
</div>

</div> <!-- End content -->
</body>
</html>
